Hoth Therapeutics Inc.

NASDAQ: HOTH · Real-Time Price · USD
1.28
-0.01 (-0.78%)
At close: Aug 15, 2025, 3:59 PM
1.28
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Hoth Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a 66.83K 46.87M
Gross Profit
n/a n/a -66.83K -46.87M
Operating Income
-8.22M -7.69M -11.07M -14.1M
Interest Income
27.71K 51.77K 6.37K n/a
Pretax Income
-8.19M -7.85M -11.37M -14.31M
Net Income
-8.19M -7.85M -11.37M -14.31M
Selling & General & Admin
4.97M 4.21M 6.13M 6.57M
Research & Development
3.25M 3.48M 4.93M 7.53M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
8.22M 7.69M 11.07M 14.1M
Interest Expense
n/a n/a 305.41K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
8.22M 7.69M 11.07M 14.1M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
6.38M 3.41M 1.2M 893.2K
Shares Outstanding (Diluted)
6.38M 3.41M 1.2M 893.2K
EPS (Basic)
-1.28 -2.3 -9.5 -16.03
EPS (Diluted)
-1.28 -2.3 -9.5 -16.03
EBITDA
-8.19M -153.15K n/a -14.1M
EBIT
-8.19M -7.85M -11.07M -14.1M
Depreciation & Amortization
8.22M 7.69M 11.07M 1.04K